Audiology Schedule

  • Date: Wednesday, March 20, 2024

    Time: 8 AM - 12 PM

    Presenters: Kristin Koch, Au.D. and Molly Howlett, Au.D.

    Abstract: This hands-on, educational workshop will cover the anatomy and physiology of the outer ear, conditions of the ear, otoscopy, properties and characteristics of cerumen, demonstration of three methods of cerumen management (including loop, irrigation, and suction) and related issues such as liability, reimbursement and regulations regarding state licensure. During this workshop, participants will be able to use a variety of cerumen removal instruments and equipment.

    Learning Objectives

    1. List and perform three methods of removing cerumen

    2. Identify three contraindications for cerumen removal with an Audiologist

    3. Describe various methods of properly cleaning and sanitizing equipment that is used for cerumen removal

    Disclosures: Howlett

    Financial: Howlett is receiving free registration from SHAV.

    Nonfinancial: Currently serving as the VP of Communications for SHAV.

    Disclosures Koch

    Financial: Koch is receiving free registration from SHAV.

    Nonfinancial: Currently serving as the VP of Audiology for SHAV.

    Important Information: This session is not included with your conference registration. The fee is $135.00 and is limited to 25 attendees.

Wednesday March 20th, 2024 (Pre-Conference Events)

Thursday Sessions

Thursday March 21st, 2024

8:00-9:00am

  • Neela Swanson, BA

    Meghan Ryan, MSL

    Track: Audiology

    Instructional Level: Intermediate

    Abstract:

    The speakers, who are members of ASHA’s health care and education policy team, will provide an overview of the state of audiology payment and policy issues, including the latest updates on billing and coding; Medicare, Medicaid, and commercial insurance coverage; and federal legislative and regulatory advocacy initiatives. The session will then dive into issues directly impacting audiologists in Virginia, such as challenges with health insurance plans and third party networks. We will have an interactive discussion regarding potential strategies to address common challenges Virginia audiologists face on a daily basis.

    Learning Objectives:

    1. Describe coding and payment updates that will impact audiologists in 2024

    2. Identify key payment and payer pain points affecting audiologists in Virginia

    3. Develop a strategy to address a key payment challenge that affects your ability to practice

    Disclosures: Swanson

    Financial: Swanson is a salaried employee of The American Speech/Language and Hearing Association- (ASHA). Swanson is also receiving monetary compensation from SHAV due to being an invited speaker.

    Nonfinancial— No relevant nonfinancial relationship exists.

    Disclosures: Ryan

    Ryan is receiving a discounted conference registration from SHAV. No other relevant financial or nonfinancial relationships to disclose.

Thursday March 21st, 2024

9:15-10:15 am

  • Neela Swanson, BA

    Meghan Ryan, MSL

    Track: Audiology

    Instructional Level: Intermediate

    Abstract:

    The speakers, who are members of ASHA’s health care and education policy team, will provide an overview of the state of audiology payment and policy issues, including the latest updates on billing and coding; Medicare, Medicaid, and commercial insurance coverage; and federal legislative and regulatory advocacy initiatives. The session will then dive into issues directly impacting audiologists in Virginia, such as challenges with health insurance plans and third party networks. We will have an interactive discussion regarding potential strategies to address common challenges Virginia audiologists face on a daily basis.

    Learning Objectives:

    1. Describe coding and payment updates that will impact audiologists in 2024

    2. Identify key payment and payer pain points affecting audiologists in Virginia

    3. Develop a strategy to address a key payment challenge that affects your ability to practice

    Disclosures: Swanson

    Financial: Swanson is a salaried employee of The American Speech/Language and Hearing Association- (ASHA). Swanson is also receiving monetary compensation from SHAV due to being an invited speaker.

    Nonfinancial— No relevant nonfinancial relationship exists.

    Disclosures: Ryan

    Ryan is receiving a discounted conference registration from SHAV. No other relevant financial or nonfinancial relationships to disclose.

Thursday March 21st, 2024

10:30-11:30am

  • Sec. John Littel

    Track: Professional

    Instructional Level: Introductory

    Abstract:

    Meet Virginia's Secretary of Health and Human Services, John Littel and learn about the 2024 General Assembly session, including key healthcare legislation from the perspective of Sec. Littel. During this advocacy-centered session, participants will have an opportunity to learn about Sec. Littel's own advocacy experiences and the value of professional advocacy. Additionally, participants will have the opportunity to ask Sec. Littel questions at the end of the presentation.

    Learning Objectives:

    1. Describe the impact of professional advocacy on state-level public policy

    2. Demonstrate an understanding of SHAV and ASHA professional issues through conversations with Sec. John Little, Virginia's Secretary of Health and Human Services

    3. Summarize outcomes from the 2024 General Assembly session

    Disclosures: Littel

    Littel is employed as Virginia’s Secretary of Health and Human Service. He has no other relevant financial or nonfinancial relationships to disclose.

Thursday March 21st, 2024

12:30-1:00pm

  • More information forthcoming.

Thursday March 21st, 2024

1:00-2:00pm

  • Nauman Manzoor MD.

    Callie Strachan AuD. CCC-A

    Avery Ryan

    Track: Audiology

    Instructional Level: Intermediate

    Abstract:

    Basic knowledge of cochlear implants as well as candidacy for this procedure is still limited among the healthcare world. A comprehensive overview of this technology and how it works will be explained. As well as a in depth guide on candidacy criteria so that clinicians, support workers, and families may be better able to identify when an individual may be in need of this technology. To follow up, a Virginia research database will be discussed to demonstrate this disparity among the people living in our state.

    Learning Objectives:

    1: Understand basic cochlear implant candidacy evaluation and identify expanded and emerging indications for cochlear implantation

    2: Describe basic functionality and components of medical evaluation for cochlear implantation and understand components of routine and complex surgeries

    3: Identify activation and cochlear implant programming process and understand the importance of auditory rehabilitation for the adult and pediatric cochlear implant population

    Disclosures: Manzoor

    Financial: Manzoor is receiving monetary compensation from SHAV due to being an invited speaker.

    Nonfinancial— No relevant nonfinancial relationship exists.

    Disclosures: Strachan

    Financial: Strachen is receiving monetary compensation from SHAV due to being an invited speaker.

    Nonfinancial— No relevant nonfinancial relationship exists.

    Disclosures: Ryan

    Ryan is receiving a discounted conference registration from SHAV. No other relevant financial or nonfinancial relationships to disclose.

Thursday March 21st, 2024

2:15-3:15pm

  • Nauman Manzoor MD.

    Callie Strachan AuD. CCC-A

    Avery Ryan

    Track: Audiology

    Instructional Level: Intermediate

    Abstract:

    The presenters will discuss the medical evaluation process of cochlear implantation. Emphasis will be placed on routine as well as more complex scenarios to give audience a thorough exposure to CI medical evaluation. Surgical practices related to routine cochlear implantation will be demonstrated. In addition, advanced techniques such as implanting an ossified and obstructed cochlea will be discussed as well. Cutting-edge technologies will be discussed including pre-operative planning for optimal implant choice, intra-operative placement check and intra-operative electrocochleography for hearing preservation. Presenters will also discuss performance of cochlear implantation under local anesthesia in select patients.

    Learning Objectives:

    1: Understand basic cochlear implant candidacy evaluation and identify expanded and emerging indications for cochlear implantation

    2: Describe basic functionality and components of medical evaluation for cochlear implantation and understand components of routine and complex surgeries

    3: Identify activation and cochlear implant programming process and understand the importance of auditory rehabilitation for the adult and pediatric cochlear implant population

    Disclosures: Manzoor

    Financial: Manzoor is receiving monetary compensation from SHAV due to being an invited speaker.

    Nonfinancial— No relevant nonfinancial relationship exists.

    Disclosures: Strachan

    Financial: Strachen is receiving monetary compensation from SHAV due to being an invited speaker.

    Nonfinancial— No relevant nonfinancial relationship exists.

    Disclosures: Ryan

    Ryan is receiving a discounted conference registration from SHAV. No other relevant financial or nonfinancial relationships to disclose.

Thursday March 21st, 2024

3:30-4:30 pm

  • Nauman Manzoor MD.

    Callie Strachan AuD. CCC-A

    Avery Ryan

    Track: Audiology

    Instructional Level: Intermediate

    Abstract:

    How a patient may succeed with a cochlear implant could be looked at as a recipe. Certain pre and post operative factors are components of this recipe that can provide insight or possible predictions on cochlear implant performance, and which are necessary to discuss. Aural rehabilitation CI strategies and its impact on performance will also be highlighted. Additionally, expectations and realities of using a cochlear implant will be explained. A demonstration will be provided to show how a cochlear implant may possibly sound, as well as typical reactions/sound experiences when the device is activated. What occurs during a cochlear implant mapping session will be broken down. Lastly, some real-time case studies of will be provided for examination.

    Learning Objectives:

    1: Understand basic cochlear implant candidacy evaluation and identify expanded and emerging indications for cochlear implantation

    2: Describe basic functionality and components of medical evaluation for cochlear implantation and understand components of routine and complex surgeries

    3: Identify activation and cochlear implant programming process and understand the importance of auditory rehabilitation for the adult and pediatric cochlear implant population

    Disclosures: Manzoor

    Financial: Manzoor is receiving monetary compensation from SHAV due to being an invited speaker.

    Nonfinancial— No relevant nonfinancial relationship exists.

    Disclosures: Strachan

    Financial: Strachen is receiving monetary compensation from SHAV due to being an invited speaker.

    Nonfinancial— No relevant nonfinancial relationship exists.

    Disclosures: Ryan

    Ryan is receiving a discounted conference registration from SHAV. No other relevant financial or nonfinancial relationships to disclose.

Thursday March 21st, 2024

4:45-5:45pm

  • Treasyri Williams Wood SLPD, CCC-SLP/L

    Track: Professional

    Instructional Level: Introductory

    Abstract:

    This keynote address will outline and will discuss strategies for successful advocacy, opportunities to lead, and ways to get involved. Issues described in ASHA’s 2024 Public Policy Agenda (PPA) will be highlighted as well as strategies for how speech-language pathologists and audiologists can harness their leadership potential to promote advocacy efforts to ensure favorable outcomes for members and consumers in their state

    Learning Objectives:

    1. Identify one priority in each of the five objective areas of Health Care Issues, Schools Issues, Professional Practice and Workforce, Client/Patient/Student Issues, and Diversity, Equity, and Inclusion Issues in the Public Policy Agenda

    2. Identify three leadership skills members who volunteer for ASHA’s Committees, Boards and Councils develop

    3. Describe at least three traits common to great leaders

    Disclosures: Williams-Wood

    Williams-Wood is employed by ASHA. She has no relevant financial or nonfinancial relationships to disclose.

    DEI

Thursday March 21st, 2024

5:30pm

  • More information forthcoming.

Friday Sessions

Friday March 22nd, 2024

8:00-9:00am

  • Debra Ogilvie AUD

    Kelley Smith JD

    Bruce Wagner M.Ed

    Handout

    Track: Audiology

    Instructional Level: Introductory

    Abstract:

    Join us for an informative presentation led by esteemed board members and the Executive Director of the Virginia Board for Hearing Instrument Specialists and Opticians as we delve into the current landscape of rules and regulations governing hearing instrument specialists (HIS) in the state. This session will not only review the current regulations but will specifically emphasize and delve into recent updates and pending legislation that stand poised to significantly impact the landscape of the hearing instrument specialists' profession in Virginia.

    We recognize the importance of open dialogue, and to that end, the presentation will conclude with a dedicated Q&A session. Attendees are encouraged to actively participate, seeking clarification on specific regulations or gaining insights into the potential implications of upcoming changes. This interactive segment aims to create a dynamic platform for knowledge exchange and mutual understanding.

    Don’t miss this invaluable opportunity to enhance your knowledge, navigate current regulations, and prepare for the future landscape of HIS in Virginia. Your questions and contributions are valued, shaping the dialogue and ensuring a shared commitment to excellence in our profession.

    Learning Objectives:

    Disclosures: Ogilvie

    Ogilvie has no relevant financial or nonfinancial relationships to disclose.

    Disclosures: Smith

    Smith has no relevant financial or nonfinancial relationships to disclose.

    Disclosures: Wagner

    Wagner as no relevant financial or nonfinancial relationships to disclose.

    Ethics

Friday March 22nd, 2024

9:15-10:15am

  • Shari Robertson Ph.D. CCC-SLP, BCS-CL, ASHA Fellow, Professor Emeria

    Handout

    Track: Professional

    Instructional Level: Intermediate

    Abstract:

    Supervising is a rewarding undertaking, but it brings with it some challenges and stressors. When areas of concern arise, it is tempting to put off having a difficult conversation with a student clinician, intern, or supervisee in the hopes that the problem will go away. Unfortunately, when we avoid hard conversations, problems become bigger, tempers become hotter, and we lose the opportunity to model professional behaviors that contribute to more psychologically safe workplaces. This seminar will provide participants with a solution-oriented, step-by-step approach to starting and managing difficult conversations. Imagine less stress, more trust, and better outcomes for both you and your supervisees. You've got this!

    Learning Objectives:

    Identify the desired outcome of a difficult conversation with supervisees

    Discuss the steps for initiating and managing difficult conversations

    Develop an action plan to apply strategies to difficult conversations in your professional setting

    Financial Disclosures: Robertson receives Royalty, Ownership interest (e.g. stock, stock options or other ownership interest, excluding diversified mutual funds) from Dynamic Resources, LLC

    Nonfinancial— No relevant nonfinancial relationship exists.

    Supervision

Friday March 22nd, 2024

10:30-11:30am

  • Leslie Knachel

    Track: Professional

    Instructional Level: Introductory

    Abstract:

    Updates from the Board of Audiology and Speech-Language Pathology will be provided including changes to the laws and regulations, revisions and additions to guidance documents, and an opportunity for the audience to ask questions.

    Learning Objectives:

    Identify areas on the Board's website

    Describe recent updates to laws and regulations

    Explain updates to guidance documents

    Disclosures: Knachel

    Knachel has no relevant financial or nonfinancial relationships to disclose.

    No CEU credit available for this course.

Friday March 22nd, 2024

12:30-1:00pm

  • More information forthcoming.

Friday March 22nd, 2024

1:00-2:00pm

  • Madison Brumbaugh MS, CCC-SLP

    Track: Professional

    Instructional Level: Introductory

    Abstract:

    Learn about SHAV's lobbying efforts during the 2024 General Assembly session, including SHAV's Advocacy Day turnout, bills passed and rejected, and follow-up activities planned by SHAV to ensure future success during the 2025 legislative session. During the Hot Topics session, ideas for more comprehensive and inclusive advocacy efforts are always welcome. The session will also end with an advocacy-related activity for members to complete.

    Learning Objectives:

    Identify examples of public policy initiatives led or supported by SHAV

    Describe advocacy actions that they may be able to implement

    Apply advocacy knowledge by connecting with their state legislators

    Disclosures: Brumbaugh

    Brumbaugh has no relevant financial or nonfinancial relationships to disclose.

    ASHA CE 0.1

    0.1 AAA CEU

Friday March 22nd, 2024

2:15-3:15pm

  • Ayasakanta Rout, Ph.D.; James Madison University

    Track: Audiology

    Instructional level: Intermediate

    Abstract:

    Disruptive innovations in audiology have necessitated a re-examination of clinical practice and training of future audiologists. In this presentation, a data-driven approach will be shared to examine disruptive innovations (AI-powered hearing aids, OTC devices, and new practice models among others).

    Learning Objectives:

    List the disruptive innovations in the field of audiology

    Understand the supply chain in hearing aid manufacturing

    Learn the role of artificial intelligence (AI) in hearing aid signal processing and programming.

    Disclosures: Rout

    Rout has no relevant financial or nonfinancial relationships to disclose.

    ASHA CE 0.1

    0.1 AAA CEU

    Ethics

Friday March 22nd, 2024

3:30-4:30pm

  • Ayasakanta Rout, Ph.D.; James Madison University

    Track: Audiology

    Instructional Level: Intermediate

    Abstract:

    Following the release of the Food and Drug Administration (FDA) guidelines, several OTC hearing aids are currently available in the market. However, there is limited information available for public education and practicing audiologists regarding OTC devices. This presentation will summarize the FDA guidelines and the existing research literature on OTC hearing aids.

    Learning Objectives:

    List the FDA guidelines for over-the-counter hearing aids

    Understand the ASHA survey results of OTC hearing aid adoption and perceptions by the general public

    Synthesize a summary of important peer-reviewed literature on OTC hearing aids

    Disclosures: Rout

    Rout has no relevant financial or nonfinancial relationships to disclose.

    ASHA CE 0.1

    0.1 AAA CEU

Friday March 22nd, 2024

4:45-5:45pm

  • Ayasakanta Rout, Ph.D.; James Madison University

    Track: Audiology

    Instructional Level: Intermediate

    Abstract:

    Following the release of the Food and Drug Administration (FDA) guidelines, several OTC hearing aids are currently available in the market. However, there is limited information available for public education and practicing audiologists regarding OTC devices. This presentation will summarize the FDA guidelines and the currently available OTC hearing aids in the market.

    Learning Objectives:

    List the FDA guidelines for over-the-counter hearing aids

    List currently available OTC hearing aids

    Apply the information on OTC hearing aids to their clinical practice

    Disclosures: Rout

    Rout has no relevant financial or nonfinancial relationships to disclose.

    ASHA CE 0.1

    0.1 AAA CEU